Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Browsing Tag

common

4 posts
SSwitzerland
Wall Street
Read More

Two Swiss IPOs in one day

  • 2026-11-13
Today, two Swiss life sciences companies – Windward Bio and vVARDIS – are going public. The Basel-based biotech…
SSwitzerland
Sick Pay in Swiss Construction: Five Collective Agreements, One Common Rate — but the Fine Print V
Read More

Sick Pay in Swiss Construction: Five Collective Agreements, One Common Rate — but the Fine Print V

  • 2026-10-06
Construction workers in Switzerland can count on the same headline benefit when illness strikes, regardless of which trade…
GGeneva
Can China and US find common ground on AI governance in Geneva?
Read More

Can China and US find common ground on AI governance in Geneva?

  • 2026-07-07
Representatives from China and the U.S. are searching for areas of agreement on how to govern artificial intelligence…
RRoche
New England Journal of Medicine publishes phase III ALLEGORY data showing Roche’s Gazyva/Gazyvaro significantly reduces disease activity in the most common form of lupus
Read More

New England Journal of Medicine publishes phase III ALLEGORY data showing Roche’s Gazyva/Gazyvaro significantly reduces disease activity in the most common form of lupus

  • 2026-03-06
Over three quarters of people on Gazyva/Gazyvaro plus standard therapy achieved at least a four-point improvement in SRI-4,…
Switzerland
www.europesays.com